The EU is set to routinely disclose the proportion of clinical trials for which sponsors have met their obligation to submit results, in an effort to improve compliance with transparency requirements.
The EU is set to routinely disclose the proportion of clinical trials for which sponsors have met their obligation to submit results, in an effort to improve compliance with transparency requirements.